REVB Revelation Biosciences Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: REVB

Price (delayed)

$1.05

Market cap

$4.1M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$22.76

Enterprise value

-$9.25M

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 8
Highlights
The quick ratio has soared by 193% year-on-year and by 86% since the previous quarter
The EPS has surged by 97% year-on-year and by 5% since the previous quarter
The net income is up by 31% YoY but it is down by 11% QoQ
Sector: Healthcare
Industry: Biotechnology
Peers: OLMA OMER VIVS ORIC

Key stats

What are the main financial stats of REVB

REVB stock price

How has the Revelation Biosciences stock price performed over time
Intraday
0.96%
1 week
-4.55%
1 month
-2.78%
1 year
-90.1%
YTD
-67.19%
QTD
-12.5%

Financial performance

How have Revelation Biosciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$10.07M
Net income
-$9.87M
Gross margin
N/A
Net margin
N/A
The net income is up by 31% YoY but it is down by 11% QoQ
REVB's operating income is down by 23% YoY and by 11% from the previous quarter

Price vs fundamentals

How does REVB's price correlate with its fundamentals

Growth

What is Revelation Biosciences's growth rate over time

Valuation

What is Revelation Biosciences stock price valuation
P/E
N/A
P/B
0.3
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has surged by 97% year-on-year and by 5% since the previous quarter
The price to book (P/B) is 87% lower than the 5-year quarterly average of 2.3
REVB's equity is up by 47% since the previous quarter

Efficiency

How efficient is Revelation Biosciences business performance
REVB's return on equity has surged by 54% year-on-year but it is down by 4.8% since the previous quarter
The company's return on assets fell by 9% QoQ

Dividends

What is REVB's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for REVB.

Financial health

How did Revelation Biosciences financials performed over time
The quick ratio has soared by 193% year-on-year and by 86% since the previous quarter
The company's current ratio has surged by 178% YoY and by 85% QoQ
The debt is 94% less than the equity
REVB's equity is up by 47% since the previous quarter
REVB's debt to equity is down by 25% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.